Senate GOP Leaders Seem Determined To Hold Vote On ACA Repeal Measure Soon- Washingtonpost.com
No comment
The GOP is taking action on healthcare. Read more in this article from The Washington Post, link here: Continue Reading
Over $700,000 for a drug per year seems excessive. There is a balance between a drug company getting back their research and development costs and having a drug that is affordable . Some of the niche drugs for rare Continue Reading
Pharmacogenetics screening is a valuable tool to manage prescription drug spending. It is an important component in any prescription management program. The spending on prescription drugs for many small and medium Continue Reading
A number of years ago while I was still in the pharmaceutical industry, Sandoz spoke of an extensive pipeline of a new generation of drugs in the biological area known as bio-similars. A couple of these products Continue Reading
The CEO of Express Scripts has some valid points to assist in controlling drug costs. Bringing competitive drugs to the market certainly will help. This is especially important with Bio-similars for the high cost Continue Reading
My background includes many years in the generic pharmaceutical industry. Typically, competition would drive the pricing down to be unprofitable. Many of the competitive companies would drop out and the remaining Continue Reading